Abstract
To the editor: In a recent issue of the Journal of Bone and Mineral Research, The American Society for Bone and Mineral Research Task Force Report recommends that race/ethnicity be removed as a variable in FRAX. 1 As an interim measure, the Task Force recommends that non-White women be presented with a risk range. The lower boundary of the range would be the current FRAX race-specific estimate, and the upper boundary would be the risk derived from assigning White race to non-White women. The Task Force justifies this recommendation by pointing out that non-White women who sustain fractures have less favorable outcomes than White women. Herein, we consider the potential impact that implementing the Task Force interim recommendations would have on clinical practice in two sample cases: We commend the Task Force for addressing this important issue and for its research recommendations. We recognize the complexity of this question including the well-documented differences in BMD, fracture risk, and postfracture outcomes among racial groups in the United States. However, we have objections to the recommendation that race be removed from considering fracture risk in FRAX. Treating more low-risk patients is not the solution to the myriad factors resulting in poorer health outcomes among non-White persons.

This publication has 1 reference indexed in Scilit: